# Tyra Biosciences, Inc.: Form SCHEDULE 13D/A, filed Jun 6, 2025

- Company: [Tyra Biosciences, Inc.](/companies/tyra.md) (CIK 1863127)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-06
- Accepted by EDGAR: Jun 6, 2025, 16:50 ET
- Period: not reported
- Accession: 0001415889-25-016006
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1863127/000141588925016006/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1863127/000141588925016006/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1863127/000141588925016006/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-016006. Last ingested by Listed: Oct 27, 2026, 17:31 ET. No prices; not investment advice.